The only microfocused ultrasound with real-time visualisation (MFU–V)1-3

PROVEN BY SCIENCE.
MASTERED BY YOU.1,4,5

Get in touch

Innovative non-invasive skin lifting and tightening technology, for visible, reproducible results1,2

The Gold Standard for nonsurgical lifting and skin tightening.

Why choose Ultherapy®?

Ultherapy® delivers a high level of patient satisfaction.6,7

  • Visible improvements in 3 months7,10
  • A single treatment is usually all that’s needed for results that can last over a year*1,10,12
  • Minimal downtime after treatment12

Get in touch

Our collagen levels are depleting at a rate of 1% a year from the age of 25, so it comes as no surprise that there is increasing awareness of the benefits of collagen-regenerating treatments such as Ultherapy®, especially among individuals aged 29–45 years, 70% of all Ultherapy® patients. This skin-savvy audience has recognised the benefits of investing in their ‘collagen bank’ for better skin in the longer term and using it as a preventative method.

Dr Tracy Mountford

Founder of The Cosmetic Skin Clinic

Authentic Ultherapy.

Offer Ultherapy® in your clinic today–the only authentic micro-focused ultrasound with visualisation skin lifting and tightening device available in the UK and Ireland

How is Ultherapy® Different?

Adverse events should be reported to Merz Pharma UK Ltd by email to UKdrugsafety@merz.com or call +44 (0) 333 200 4143
Reporting forms and information are available for the UK here: www.yellowcard.mhra.gov.uk and for the Republic of Ireland here: https://www.hpra.ie/homepage/about-us/report-an-issue

 

*For patients with mild to moderate skin laxity. Individual results may vary

References:
  1. Fabi SG, et al. J Drugs Dermatol. 2019;18(5):426–432.
  2. ULTHERAPY® EU 1001393IFU Rev N IFU, CONTROL UNIT IFU _Final.
  3. Ulthera Press Release: Ultherapy® décolletage treatment now FDA-cleared. BioSpace website. Available at: https://www.biospace.com/article/releases/ulthera-release-ultherapy-and-0174-d%C3%A9colletage-treatment-now-fda-cleared-/ Accessed: July 2021.
  4. White WM, et al. Arch Facial Plast Surg. 2007;9(1):22–29.
  5. Ultherapy®2021 Data on File: Ref-0992.
  6. Ulthera System 501(k) Summary. U.S. Food & Drug Administration website. Available at: www.accessdata.fda.gov/cdrh_docs/pdf13/k134032.pdf Accessed: July 2021.
  7. Werschler WP & Werschler PS. J Clin Aesthet Dermatol. 2016;9(2):27–33.
  8. American Society for Aesthetic Plastic Surgery. 2015 Cosmetic surgery national data bank statistics. Available at: https://www.surgery.org/sites/default/files/ASAPS-Stats2015.pdf Accessed: July 2021.
  9. The American Society for Aesthetic Plastic Surgery. 2016 Cosmetic surgery national data bank statistics. https://www.surgery.org/sites/default/files/ASAPS-Stats2016.pdf Accessed: July 2021.
  10. Kerscher M, et al. Clin Cosmet Investig Dermatol. 2019;12:71–79.
  11. Brobst RW, et al. Facial Plast Surg Clin N Am. 2014;22:191–202.
  12. Sasaki GH & Tevez A. JCDSA. 2012;2:108–116.

As seen in